By: Ethan Rogers
Long before Karthik Achari became a founder or stepped into a national conversation about healthcare standards, his career began in the Chicago area.
Born in the Chicago suburbs and raised in Bolingbrook and Naperville, Achari went to college in downtown Chicago before beginning a professional journey that would eventually take him from clinical care to nursing leadership, entrepreneurship, manufacturing and, ultimately, the creation of an independent healthcare standards body.
Today, Achari splits his time between Chicago and Los Angeles and serves as the Clinician and Founder of PepMD.
While the organization represents the newest chapter of his career, Achari believes its foundation was built through years of seeing healthcare from positions that rarely overlap.
He has worked directly in clinical environments. He has been responsible for other clinicians as a nursing director. He has built companies. He has experienced precision diagnostics, pharmaceutical and nutraceutical manufacturing and distribution, and the complex systems of compliance surrounding them.
That journey eventually led him to a deceptively simple conclusion:
Healthcare has plenty of reputation. What it increasingly needs is verification.
“A good reputation tells you what people believe,” Achari says. “Verification tells you what is true.”
A Career That Started on the Clinical Side
Achari’s earliest professional experiences were not those of a founder.
He began as a clinician.
He later became a nursing director, taking responsibility for clinical teams and seeing firsthand how healthcare systems translate standards from documents into everyday decisions.
The experience fundamentally shaped how he views accountability.
A standard can exist on paper, Achari learned, but it only becomes meaningful when somebody verifies that it is being followed.
That responsibility becomes particularly clear in healthcare, where documentation, competence, escalation, and compliance can directly affect patient safety.
As a nursing director, Achari was no longer responsible only for his own clinical work. He was accountable for the performance and competence of others.
Those years would later become one of the biggest influences on his leadership philosophy.
“Standards only mean something when someone is responsible for verifying them,” he says.
Eventually, Achari moved from working within healthcare organizations to building companies of his own.
Seeing Healthcare From the Other Side
Achari went on to found businesses in precision diagnostics and pharmaceutical and nutraceutical manufacturing and distribution.
The transition gave him a perspective he could not have developed solely from clinical practice.
He had previously worked inside systems responsible for enforcing standards.
Now, he was operating businesses required to live under them.
The experience showed him how much of healthcare quality ultimately comes down to individual decisions that patients and consumers may never see.
Whether someone documents a problem.
Whether a concern gets escalated.
Whether quality is independently checked.
Whether an organization chooses the more difficult path when the easier one might still be commercially advantageous.
Achari began thinking less about reputation and more about how trust itself could be demonstrated.
That distinction eventually became central to what he wanted to build next.
Walking Away to Build Something Independent
Achari’s next move required a significant personal and professional risk.
He fully divested his previous business interests.
These were not companies he had merely invested in from a distance. They were operating businesses he had helped build.
But Achari believed maintaining commercial interests in the industry while simultaneously establishing standards for it would undermine the independence of what he was trying to create.
The safer decision would have been to retain those interests.
He chose the opposite.
“I gave up the safer position to make the more important one possible,” Achari says.
On January 1, 2026, PepMD was founded.
Achari structured the organization around a principle he had increasingly come to believe throughout his career: trust should be demonstrable rather than assumed.
The standard, credentialing decisions, and registry sit within a nonprofit entity, separate from commercial services.
That separation is designed to protect the independence of the decisions being made.
For Achari, the structure matters as much as the standard itself.
From Chicago to an FDA Public Hearing
By July 2026, Achari found himself participating in a conversation at the federal level.
That month, he delivered public comment during the Open Public Hearing at the FDA’s Pharmacy Compounding Advisory Committee meeting.
The distinction is important: Achari did not testify before the FDA. He delivered public comment as part of the committee’s Open Public Hearing.
For him, the experience represented a turning point.
The advisory committee considered questions affecting the future of compounded medicine, including votes recommending six compounds for potential inclusion on the compounding list. Those votes were advisory recommendations rather than approvals, with formal rulemaking still to follow.
Achari saw something larger in the discussion.
The regulatory process could determine what pharmacies may eventually be permitted to compound, but he believed another question remained outside that process: how patients and institutions determine who has demonstrated specific qualifications to work within an emerging area of care.
Walking out of the FDA’s White Oak campus, Achari felt the need for independent infrastructure had become clearer.
The question, in his mind, was no longer simply whether such infrastructure was necessary.
It was who could build it credibly.
The Chicago Roots Behind PepMD
Although PepMD operates within a national healthcare conversation, Achari’s Chicago background remains an important part of his story.
His path through the region exposed him to healthcare first through education and clinical work rather than entrepreneurship.
That distinction matters to him.
The founder came after the clinician.
The business experience came after seeing how patient care and clinical accountability function from the inside.
Today, those experiences converge within PepMD.
The organization is developing a single standard spanning three functions: clinician credentialing, pharmacy recognition, and research site authorization.
The purpose is not to replace existing regulatory systems.
PepMD is not a regulator.
Instead, the organization is building an independent framework through which qualifications and recognition can be evaluated and verified against published criteria.
For Achari, the difference between being legally permitted to do something and demonstrating that it is trustworthy is increasingly important as healthcare evolves.
Recognizing the People Doing Things Right
There is another side of the mission that Achari believes can get overlooked.
Standards are often discussed as mechanisms for identifying problems.
Achari also views them as a way to recognize professionals who are already doing things carefully.
“There are excellent clinicians and pharmacists whose diligence is invisible because no standard exists to recognize it,” he says.
Those professionals, he argues, are precisely the people independent credentialing should help distinguish.
Achari does not expect every operator to seek greater scrutiny.
The value comes from giving those willing to meet published criteria a way to demonstrate that commitment.
In that sense, PepMD’s work is as much about recognition as accountability.
Building a Stronger Evidence Base
Achari’s longer-term ambitions also extend into research.
PepMD is developing registry work under IRB governance with the goal of helping an emerging area of healthcare generate governed data rather than relying primarily on anecdotes.
That is ultimately one of the parts of the organization Achari considers most important.
He wants better standards to produce better information.
And he wants better information to help clinicians, institutions, policymakers, and patients make more informed decisions.
The organization is currently scaling clinician credentialing while preparing pharmacy recognition with an initial tier of national compounding pharmacies.
Institutional partnership discussions are also active.
But Achari says the focus remains on depth before breadth.
Making Trust Verifiable
Achari’s career has taken him through clinical care, nursing leadership, diagnostics, manufacturing, entrepreneurship, and now healthcare standards.
The common thread is accountability.
His Chicago roots placed him inside healthcare before he ever thought about creating an independent standards body. His years as an entrepreneur later showed him what standards look like from the businesses expected to meet them.
Eventually, those experiences converged.
PepMD is the result.
For Achari, the broader mission can be reduced to a principle that has increasingly defined his career:
Verifiable rather than assumed.
As healthcare continues to evolve, Achari believes trust cannot depend solely on reputation, marketing, or what an organization says about itself.
It needs infrastructure behind it.
And for a founder whose career began in the Chicago healthcare community, building that infrastructure has become the next chapter.
To learn more about Karthik Achari and PepMD, including its published standards, credentialing framework, and partnership opportunities, visit PepMD’s official website.
